We send the latest information from SMC Laboratories.
CytoDyn Inc., which is our client, has announced the results of pharmacology study using a STAM™ mouse model. …
We introduce a case study of pharmacology study of adiponectin-derived peptide ALY688 using our MASH model (ST…
Our clients presented data on treatment of MASH using STAMTM model at the AASLD ~The Liver Metting 2024~ (Nove…
We want to introduce a paper by Insilico Medicine, a company that focuses on fibrosis to develop drugs, and af…
We recently obtained new evaluation data on the Lenvatinib in our STAM model and it shows significantly improv…
We are introducing new disease models to our portfolio of preclinical mouse models. Our extensive lineup offer…
Recently, we have obtained the results of a study of resmetirom for the treatment of fibrosis using STAMTM-HCC…
Today, we introduce the pre-clinical studies in MASH drug development targeting Gut-Liver axis. In MASH…
We introduce a case study of drug efficacy evaluation of Mesenchymal stem/stromal cell-derived small extracell…
Today, we share an update regarding new preclinical service. It is now possible to use a positive control (Rof…